Clinical Trials Logo
  1. Home
  2. Drug Allergy
  3. NCT04920721
  4. Details
NCT04920721 Clinical Trial

Retrospective Study of Immediate Hypersensitivity (IHS) Reactions to Platinum Salts in the University Hospital of Nancy

Drug Allergy Clinical Trial

Official title:
Retrospective Study of Immediate Hypersensitivity (IHS) Reactions to Platinum Salts in the University Hospital of Nancy

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04920721
Other study ID # 2021PI002
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 2021
Est. completion date July 2021

Study information
Verified date June 2021
Source Central Hospital, Nancy, France
Contact Tania ADAM, Dr
Email t.adam@chru-nancy.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To assess the efficacy of skin tests with platinum salts in patients suspects with immediate hypersensitivity reactions. All patients adressed in consultation to the Allergy Department of university hospital of nancy for an immediate hypersensitivity reaction to platinum salts between 2015 and 2021 were retrospectively recruited.

Recruitment information / eligibility
Status Recruiting
Enrollment 62
Est. completion date July 2021
Est. primary completion date July 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - adult - suspected immediate hypersensitivity reaction to platinum salts Exclusion Criteria: - skin tests not achievable

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• no intervention
no intervention descriptiv study

Locations
Country Name City State
France CHRU Nancy Nancy Vandoeuvre-Lès-Nancy

Sponsors (1)
Lead Sponsor Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Result of skin test prick test and if negativ => intradermoreaction baseline
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06414694 - Inpatient Penicillin Delabeling for Low-Risk Patients Phase 4
Completed NCT05706246 - Perioperative Hypersensitivity in Children N/A
Completed NCT02118987 - Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization Phase 1
Enrolling by invitation NCT03164044 - Improved Basophil Activation Test (BAT) in the Diagnostics of Drug Allergy
Completed NCT02094638 - Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study N/A
Not yet recruiting NCT06399601 - A Training Program of Drug Allergy for Healthcare Professionals N/A
Completed NCT03784482 - Multiple Drug Hypersensitivity Syndrome
Not yet recruiting NCT06406114 - Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing Phase 2
Recruiting NCT05820802 - High Dimensional Analysis of Immune Cells in Pediatric Patients